These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
216 related articles for article (PubMed ID: 20888330)
41. [PERIPHERAL ATHEROSCLEROSIS. ITS EARLY DETECTION AND SIGNIFICANCE IN GENERAL PRACTICE]. WIDMER LK Schweiz Med Wochenschr; 1963 Nov; 93():1583-91. PubMed ID: 14153111 [No Abstract] [Full Text] [Related]
42. ATHEROSCLEROSIS OBLITERANS. A CLINICAL STUDY. II. SELVAAG O J Oslo City Hosp; 1963; 13():81-152. PubMed ID: 14048362 [No Abstract] [Full Text] [Related]
43. miR-21, miR-210, miR-34a, and miR-146a/b are up-regulated in human atherosclerotic plaques in the Tampere Vascular Study. Raitoharju E; Lyytikäinen LP; Levula M; Oksala N; Mennander A; Tarkka M; Klopp N; Illig T; Kähönen M; Karhunen PJ; Laaksonen R; Lehtimäki T Atherosclerosis; 2011 Nov; 219(1):211-7. PubMed ID: 21820659 [TBL] [Abstract][Full Text] [Related]
44. Circulating microRNAs (miR-423-5p, miR-208a and miR-1) in acute myocardial infarction and stable coronary heart disease. Nabiałek E; Wańha W; Kula D; Jadczyk T; Krajewska M; Kowalówka A; Dworowy S; Hrycek E; Włudarczyk W; Parma Z; Michalewska-Włudarczyk A; Pawłowski T; Ochała B; Jarząb B; Tendera M; Wojakowski W Minerva Cardioangiol; 2013 Dec; 61(6):627-37. PubMed ID: 24253456 [TBL] [Abstract][Full Text] [Related]
45. Circulating miR-323-3p and miR-652: candidate markers for the presence and progression of acute coronary syndromes. Pilbrow AP; Cordeddu L; Cameron VA; Frampton CM; Troughton RW; Doughty RN; Whalley GA; Ellis CJ; Yandle TG; Richards AM; Foo RS Int J Cardiol; 2014 Sep; 176(2):375-85. PubMed ID: 25124998 [TBL] [Abstract][Full Text] [Related]
46. MicroRNA-19b functions as potential anti-thrombotic protector in patients with unstable angina by targeting tissue factor. Li S; Ren J; Xu N; Zhang J; Geng Q; Cao C; Lee C; Song J; Li J; Chen H J Mol Cell Cardiol; 2014 Oct; 75():49-57. PubMed ID: 24998411 [TBL] [Abstract][Full Text] [Related]
47. Systemic approach to identify serum microRNAs as potential biomarkers for acute myocardial infarction. Hsu A; Chen SJ; Chang YS; Chen HC; Chu PH Biomed Res Int; 2014; 2014():418628. PubMed ID: 24900964 [TBL] [Abstract][Full Text] [Related]
48. Clinical impact of circulating miR-133, miR-1291 and miR-663b in plasma of patients with acute myocardial infarction. Peng L; Chun-guang Q; Bei-fang L; Xue-zhi D; Zi-hao W; Yun-fu L; Yan-ping D; Yang-gui L; Wei-guo L; Tian-yong H; Zhen-wen H Diagn Pathol; 2014 May; 9():89. PubMed ID: 24885383 [TBL] [Abstract][Full Text] [Related]
49. Predictive value of circulating miR-328 and miR-134 for acute myocardial infarction. He F; Lv P; Zhao X; Wang X; Ma X; Meng W; Meng X; Dong S Mol Cell Biochem; 2014 Sep; 394(1-2):137-44. PubMed ID: 24833470 [TBL] [Abstract][Full Text] [Related]
50. Circulating MicroRNAs and the occurrence of acute myocardial infarction in Chinese populations. Huang S; Chen M; Li L; He M; Hu D; Zhang X; Li J; Tanguay RM; Feng J; Cheng L; Zeng H; Dai X; Deng Q; Hu FB; Wu T Circ Cardiovasc Genet; 2014 Apr; 7(2):189-98. PubMed ID: 24627568 [TBL] [Abstract][Full Text] [Related]
51. MicroRNA-21 is a unique signature associated with coronary plaque instability in humans by regulating matrix metalloproteinase-9 via reversion-inducing cysteine-rich protein with Kazal motifs. Fan X; Wang E; Wang X; Cong X; Chen X Exp Mol Pathol; 2014 Apr; 96(2):242-9. PubMed ID: 24594117 [TBL] [Abstract][Full Text] [Related]
52. The distribution of circulating microRNA and their relation to coronary disease. Freedman JE; Ercan B; Morin KM; Liu CT; Tamer L; Ayaz L; Kanadasi M; Cicek D; Seyhan AI; Akilli RE; Camci C; Cengiz B; Oztuzcu S; Tanriverdi K F1000Res; 2012; 1():50. PubMed ID: 24358814 [TBL] [Abstract][Full Text] [Related]
54. Prospective study on circulating MicroRNAs and risk of myocardial infarction. Zampetaki A; Willeit P; Tilling L; Drozdov I; Prokopi M; Renard JM; Mayr A; Weger S; Schett G; Shah A; Boulanger CM; Willeit J; Chowienczyk PJ; Kiechl S; Mayr M J Am Coll Cardiol; 2012 Jul; 60(4):290-9. PubMed ID: 22813605 [TBL] [Abstract][Full Text] [Related]
55. Plasma microRNA-133a is a new marker for both acute myocardial infarction and underlying coronary artery stenosis. Wang F; Long G; Zhao C; Li H; Chaugai S; Wang Y; Chen C; Wang DW J Transl Med; 2013 Sep; 11():222. PubMed ID: 24053180 [TBL] [Abstract][Full Text] [Related]
56. Circulating microRNA-126 in patients with coronary artery disease: correlation with LDL cholesterol. Sun X; Zhang M; Sanagawa A; Mori C; Ito S; Iwaki S; Satoh H; Fujii S Thromb J; 2012 Aug; 10(1):16. PubMed ID: 22925274 [TBL] [Abstract][Full Text] [Related]
57. Serum microRNAs profile from genome-wide serves as a fingerprint for diagnosis of acute myocardial infarction and angina pectoris. Li C; Fang Z; Jiang T; Zhang Q; Liu C; Zhang C; Xiang Y BMC Med Genomics; 2013 May; 6():16. PubMed ID: 23641832 [TBL] [Abstract][Full Text] [Related]
58. Circulating miR-214 is associated with the severity of coronary artery disease. Lu HQ; Liang C; He ZQ; Fan M; Wu ZG J Geriatr Cardiol; 2013 Mar; 10(1):34-8. PubMed ID: 23610572 [TBL] [Abstract][Full Text] [Related]
59. Comparing the diagnostic values of circulating microRNAs and cardiac troponin T in patients with acute myocardial infarction. Li YQ; Zhang MF; Wen HY; Hu CL; Liu R; Wei HY; Ai CM; Wang G; Liao XX; Li X Clinics (Sao Paulo); 2013 Jan; 68(1):75-80. PubMed ID: 23420161 [TBL] [Abstract][Full Text] [Related]